rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Bruce Wendel

Director

Company insider

Files Form 4 as: Director, PDS Biotechnology; Director, ImmunityBio; Director, GT Biopharma; Director, Verastem; Chief Executive Officer, Abraxis BioScience.

Every Form 4 they filed

In numbers

Trades disclosed
41
Buys
2
Sells
1
Bought
$26K
Sold
$28K
Companies
5
Companies where not an officer
4
First trade
28 Nov 2007
Last trade
18 Oct 2026
Last filed
20 Oct 2026

Companies traded

Where they are an officer
Abraxis BioScienceDirector, Officer · last 15 Oct 20100 buys · 1 sell
Everywhere else they filed: board seats, 10% stakes, other companies
PDSB PDS BiotechnologyDirector · Biotechnology · last 18 Oct 20260 buys · 0 sells
IBRX ImmunityBioDirector · Biotechnology · last 9 Jun 20260 buys · 0 sells
GTBP GT BiopharmaDirector · Biotechnology · last 27 Jan 20232 buys · 0 sells
VSTM VerastemDirector · Biotechnology · last 16 Jun 20200 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
18 Oct 2026filed 20 Oct 2026PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—22,700 at $0.00filing
9 Jun 2026filed 10 Jun 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—65,600 at $0.00filing
9 Jun 2026filed 10 Jun 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—65,600 at $0.00filing
12 Dec 2025filed 16 Dec 2025IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code A—146,020 at $0.00filing
27 Jan 2023filed 1 Feb 2023GTBP GT Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—500,000 at $0.00filing
15 Jul 2022filed 19 Jul 2022GTBP GT Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
15 Jul 2022filed 19 Jul 2022GTBP GT Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
16 Feb 2021filed 7 Oct 2021GTBP GT Biopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
16 Feb 2021filed 7 Oct 2021GTBP GT BiopharmaBiotechnologySEC FORM 4 Code A—347,572 at $0.00filing
22 Dec 2020filed 7 Oct 2021GTBP GT BiopharmaBiotechnologySEC FORM 4 Bought$12K1,374 at $8.87filing
22 Dec 2020filed 7 Oct 2021GTBP GT BiopharmaBiotechnologySEC FORM 4 Bought$3,850441 at $8.73filing
16 Nov 2020filed 7 Oct 2021GTBP GT BiopharmaBiotechnologySEC FORM 4 Bought$10K3,268 at $3.14filing
16 Jun 2020filed 18 Jun 2020VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
21 Jun 2019filed 25 Jun 2019VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
11 Jun 2018filed 13 Feb 2019VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
13 Jun 2017filed 15 Jun 2017VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
14 Jun 2016filed 16 Jun 2016VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
15 Oct 2010filed 19 Oct 2010Abraxis BioScienceoption or derivativeSEC FORM 4 Code D$4.6M138,125 at $33.21filing
15 Oct 2010filed 19 Oct 2010Abraxis BioScienceoption or derivativeSEC FORM 4 Code D$79K10,607 at $7.41filing
15 Oct 2010filed 19 Oct 2010Abraxis BioScienceoption or derivativeSEC FORM 4 Code D$4,7514,242 at $1.12filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.